Bringing the vision to reality
We agree with the Five Year Forward View that much more attention should be given to improving the health of the nation by harnessing the power of technology, by focusing on conditions that most impact patients and drive costs, and by underpinning all of this with a backbone of value and sustainability.
We strongly agree with these priorities because they are ours too.
Engaging with the NHS to help deliver the Five Year Forward View and a paperless 2020 vision is a priority for us and we work hard to support the NHS in managing long-term conditions, addressing cost-efficient prescribing and ensuring high quality joined-up care for patients.
A major shift is taking place in healthcare: consumers are becoming more informed and more educated, making the healthcare industry more patient-driven than ever. Our patients today know more, and therefore expect more from us: they look to us not only for medicines, but for interaction, information sharing and partnership.
Digital technology has the potential to change healthcare delivery in a profound way. We are working hard to support the NHS to harness these significant opportunities in a relevant, meaningful and, most important, patient-focused way.
We’re focused on innovations which positively impact patients’ lives, innovations that will help the NHS to adapt to take advantage of the opportunities that science and technology could bring to patients, carers and those who care for them.
As the largest supplier of medicines to the NHS,1 we believe we bring a unique perspective to the conversation on digital health. We have a broad portfolio of medicines – fulfilling 1 in every 6 prescriptions in the UK2 – and a variety of healthcare offerings, coupled with a range of digital solutions in various stages of development.
We are looking at how drugs, healthcare technology and analytics overlap to produce solutions for unmet patient needs.
In the UK, our range of medicines includes innovative medicines, focusing on central nervous system, pain and respiratory conditions. That's alongside our extensive range of generics and portfolio of branded generics, and our range of over-the-counter therapies.
The NHS is going through the biggest financial squeeze in its history. The increasing demand for care, driven by a growing and aging population, means that services are under huge pressure. It is estimated that there will be a £30 billion shortfall per year by 2020/213. It is because of this challenging environment that we are working hard to help the NHS do more with less to allow patients to continue to access the care and treatment they need.
More than two-thirds of the medicines dispensed by the NHS are generics, yet they cost less than one third of the NHS drugs bill4. Generic medicines save the NHS more than £13 billion in just England and Wales5. Without Teva and all the other generics companies, the drugs bill would be approximately twice its current level6.
As the largest supplier of medicines to the NHS by volume, we contribute more than £3billion of these savings per year7, helping to bring down rising healthcare costs and improve patient quality of life by increasing patient access to medicines.
With these kind of savings the NHS could employ an additional 125,000 nurses, or 100,000 first year junior doctors or 50,000 GPs each year8.
We’re helping patients get better access to the medicines they need, working on improving treatment options, helping the NHS drive down costs. We are also looking at healthcare options that are fit for the future, like new technologies, innovative devices, and a fresh approach to services.
We believe we can play a valuable role in helping the NHS manage long-term conditions, address cost-efficient prescribing and develop joined-up care, giving it the opportunity to focus on making some of the plans set out in the NHS's Five Year Forward View a reality.
We have completed a number of successful joint working initiatives with the NHS, primarily in respiratory, with many other joint working projects still on-going. Learn more about the outcomes and benefits for patients from Teva’s joint working programmes with the NHS.
Learn more about Joint Working »
More engaging than simply listening to us tell you about our future plans – we’re using touch screens to let you explore and discover for yourself what we’re all about.
Step into the Digital Health Zone and try out our Teva touchscreens. You’ll learn about:
Visit the NHS/Teva HealthTech Zone at NHS Expo – near the Central Entrance – to find out more about Teva and explore the opportunities to partner with us.